ENV-6949 | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

5,593 results for “ENV-6949”

Enveda Raises $311M Series E to Push Nature-Derived AI Drugs Through Clinical Trials

Endeavor BioMedicines' ENV-101 Shows Promise in Reversing Idiopathic Pulmonary Fibrosis in Phase II Trials

ENV-101 Shows Promising Results in Idiopathic Pulmonary Fibrosis Treatment, Reducing Pulmonary Vessel Volume

Enveda's ENV-294 Shows 85% EASI Reduction in Phase 1b Atopic Dermatitis Trial

Enveda's AI-Discovered Anti-Inflammatory ENV-294 Clears Phase 1 Safety Trial, Advances to Atopic Dermatitis Study

Enveda Advances First-in-Class Oral Therapy ENV-294 to Phase 2 Trials for Atopic Dermatitis and Asthma

Kairos Pharma Reports Zero Grade 3+ Toxicities in Phase 1 Trial of ENV-105 for EGFR-Mutated Lung Cancer

Enveda's AI-Driven Natural Product Candidate ENV-294 Enters Phase I for Atopic Dermatitis

Enveda Receives FDA Clearance for First-in-Class Oral Obesity Therapy ENV-308, Doses First Patient in Phase 1 Trial

GeNeuro's GNK-301 Shows Promise in Precision Medicine Approach for ALS

Page 1 of 21